VLA 0.00% $1.75 viralytics limited

some press coverage at least.

  1. 128 Posts.
    lightbulb Created with Sketch. 3
    Evening all,

    Impossible to understand how a company can have a trial in cancer treatment can have results like this and share Price rise moderately for a few days before settling down

    At least there has been some press coverage....


    http://news.smh.com.au/breaking-news-business/viralytics-shares-surge-on-cancer-trial-20130918-2tyln.html


    http://online.wsj.com/article/PR-CO-20130918-904790.html


 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.